Ekso Bionics Holdings Balance Sheet Health
Financial Health criteria checks 4/6
Ekso Bionics Holdings has a total shareholder equity of $14.9M and total debt of $5.4M, which brings its debt-to-equity ratio to 36%. Its total assets and total liabilities are $29.2M and $14.3M respectively.
Key information
36.0%
Debt to equity ratio
US$5.36m
Debt
| Interest coverage ratio | n/a |
| Cash | US$8.29m |
| Equity | US$14.87m |
| Total liabilities | US$14.34m |
| Total assets | US$29.21m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 23E2's short term assets ($21.1M) exceed its short term liabilities ($7.5M).
Long Term Liabilities: 23E2's short term assets ($21.1M) exceed its long term liabilities ($6.8M).
Debt to Equity History and Analysis
Debt Level: 23E2 has more cash than its total debt.
Reducing Debt: 23E2's debt to equity ratio has reduced from 51.5% to 36% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 23E2 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 23E2 has less than a year of cash runway if free cash flow continues to grow at historical rates of 9.1% each year.